CDK2-IN-73 free base · Synonyms: CDK2-IN-4
CDK2-IN-4 is a potent and selective CDK2 inhibitor.
For research use only. Not for human or veterinary use.
Purity >98%
Stock Inquire
CDK2-IN-73 structure
CAS No.: 2079895-42-2
Pack sizes & pricing
Description
CDK2-IN-4 is a potent and selective CDK2 inhibitor with an IC50 of 44 nM for CDK2/cyclin A.
Biological activity
In Vitro CDK2-IN-4 (compound 73) demonstrates appreciable nanomolar potency versus CDK2 in isolated kinase assays, the maximal concentration tested in cellular assays (30 μM) had no or limited effects on the growth of cells.
Identifiers
- SMILES
-
O=S(C1=CC=C(C=C1)NC2=NC3=NC=NC3=C(C4=CC(C5=CC=CC=C5)=CC=C4)N2)(N)=O - InChIKey
-
FUGRWXRQJGJIER-UHFFFAOYSA-N
Specifications
- MW (average)
- 442.4930
- Formula
- C23H18N6O2S
- CAS No.
- 2079895-42-2
- Physical state
- Solid
- Color
- White to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder 4°C, sealed storage, away from moisture and light; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
Documents
References
[1]. Coxon CR, et al. Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines. J Med Chem. 2017 Mar 9;60(5):1746-1767.
Same target
Search CDKSame research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%
- BP-00044 Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP free base · >98%